Day: September 17, 2026

Rhelion Life Sciences’ Wholly Owned Subsidiary Filament Health Signs Supply and Licensing Agreement with the Centre for Human Drug Research for PEX010 in a Study of Low and Medium Dose Psilocybin

Dualitas Therapeutics Announces Proximity Biology Research Collaboration with Roche to Discover and Develop Novel Bispecific Antibodies for I&I Diseases

Dualitas will use its DualScreen™ Bispecific Discovery Engine to functionally screen more than 300,000 novel bispecific combinations for Immunology &...

error: Content is protected !!